Search Results (19)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Capturing functional epigenomes for insight into metabolic diseases. | Academic Article |
Why?
|
Essential nutrient supplementation prevents heritable metabolic disease in multigenerational intrauterine growth-restricted rats. | Academic Article |
Why?
|
Understanding etiology of metabolic diseases by integrative genomics and epigenomics approaches | Grant |
Why?
|
Bisphosphonates use in children. | Academic Article |
Why?
|
Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children. | Academic Article |
Why?
|
Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements. | Academic Article |
Why?
|
Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings. | Academic Article |
Why?
|
Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype. | Academic Article |
Why?
|
Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. | Academic Article |
Why?
|
Sedentary Behavior and Cardiometabolic Health Associations in Obese 11-13-Year Olds. | Academic Article |
Why?
|
Single-cell analysis of human adipose tissue identifies depot and disease specific cell types. | Academic Article |
Why?
|
Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children. | Academic Article |
Why?
|
The developmental origins of adult disease. | Academic Article |
Why?
|
The impact of estradiol on bone mineral density is modulated by the specific estrogen receptor-alpha cofactor retinoblastoma-interacting zinc finger protein-1 insertion/deletion polymorphism. | Academic Article |
Why?
|
Use of calcimimetics in children with normal kidney function. | Academic Article |
Why?
|